Sheinbaum says US 'won't' attack cartels on Mexican soil Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both ...
Q3 2025 Management View CEO Richard Miller emphasized continued progress in the development of soquelitinib for atopic ...
Q3 2025 Management View CEO Christopher Peetz stated that "2025 continues to be an outstanding year for Mirum" and highlighted strong commercial results, pipeline progress, and a strengthened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback